Should you buy Meridian Bioscience stock? (NasdaqGS:VIVO). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that Meridian Bioscience can grow its free cash at a rate of about 9%. That's positive!
(Meridian Bioscience stock price per share)
||VIVO Fair Price
(based on intrinsic value)
||VIVO Safety Price (based on a variable margin of safety)||$8.64|
||PE Ratio versus Sector||35% higher than other Healthcare stocks|
|PE Ratio versus Industry||84% lower than other Diagnostic Substances stocks|
|Free Cash Flow Jitter||19%|
We believe that Meridian Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Meridian Bioscience looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Does Meridian Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles